Resources Contact Us Home
Microdose therapy

Image Number 2 for United States Patent #6610652.

Methods for treating vascular conditions associated with localized imbalance in vascular tone, which are hypothesized to be largely due to elevated endothelin (ET) are provided. The methods involve administration of nitric oxide (NO), agents which are able to provide NO, such as NO donors, agents which activate guanyl cyclase, such as YC-1, or agents which prolong the actions of endogenous NO or cyclic guanosine monophosphate (cGMP; a 2nd messenger molecule), such as phosphodiesterase (PDE) inhibitors. According to the invention, such agents are administered in minimal doses or microdoses by any route known in the art, so as to provide dosages which are about one half to about one twentieth (1/2 to 1/20) of those known to induce vasodilation in "normal" circulations. The low doses of these agents effectively alleviate vascular conditions associated with a reduction in NO production or an attenuation of NO effect, by restoring balance in vascular tone while exerting almost no systemic effect in normal vasculature.

  Recently Added Patents
Semiconductor device and manufacturing method
Documentation roadmaps and community networking for developers on large projects
Management of temporal data by means of a canonical schema
Categorization of design rule errors
Human and mouse targeting peptides identified by phage display
Case for electronic device
High conductive water-based silver ink
  Randomly Featured Patents
Roll control device of vehicle manageable of sudden failure of rolling condition detection means
Apparatus for increasing the filling capacity of tobacco
Front cover of a handset
Methods and systems for a network element database migration service
Circuit for forming a vertical synchronizing signal
Cooling fabric
Integrated global positioning system receiver
Method of manufacturing N-carboxyamino acid anhydride and polyamino acid
Doped lignin polymer